Cyclacel Pharma (CYCC) Reports Q4 Loss of $0.17/Share

Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.17), versus ($0.14) reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• RH (RH) Tops Q2 EPS by $2.31
• KeyBanc Starts Oiln (OLN) at Overweight